ADENOSINE
- Product NDC
- 51662-1631
- 11-digit product format
- 516621631
- Labeler code
- 51662
- Product ID
- 51662-1631_fa6eb0f8-7c42-2e17-e053-6294a90ac8ca
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ADENOSINE
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA078686
- Marketing category
- ANDA
- Marketing start
- 2023-04-28
- Substance
- ADENOSINE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ADENOSINE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ADENOSINE | 3 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | K72T3FS567 |
| Rxcui | 1654169 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1631-1 | ADENOSINE | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 2 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1631 | ADENOSINE INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 1 | Current NDC, 1 package rows | 20230430_fa6eb0f8-7c41-2e17-e053-6294a90ac8ca.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51662-1631-1 | 51662163101 | 2 mL in 1 VIAL, SINGLE-DOSE (51662-1631-1) | 2 ml | 2023-04-28 | No | No | Current |